Costello Asset Management, Inc Arrowhead Pharmaceuticals, Inc. Transaction History
Costello Asset Management, Inc
- $260 Million
- Q2 2025
A detailed history of Costello Asset Management, Inc transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Costello Asset Management, Inc holds 940 shares of ARWR stock, worth $39,846. This represents 0.01% of its overall portfolio holdings.
Number of Shares
940
Previous 990
5.05%
Holding current value
$39,846
Previous $12,000
16.67%
% of portfolio
0.01%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding ARWR
# of Institutions
328Shares Held
99.7MCall Options Held
444KPut Options Held
568K-
Black Rock Inc. New York, NY15.7MShares$665 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.5MShares$658 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY10.6MShares$449 Million3.05% of portfolio
-
State Street Corp Boston, MA6.37MShares$270 Million0.0% of portfolio
-
Slate Path Capital LP New York, NY5.23MShares$222 Million1.65% of portfolio
About ARROWHEAD PHARMACEUTICALS, INC.
- Ticker ARWR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 105,849,000
- Market Cap $4.49B
- Description
- Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...